Neil R. Ackerman

Neil R. Ackerman

Plus aucun poste en cours

Fortune : 4 M $ au 31/05/2024

81 ans
Health Technology
Consumer Services
Finance

Profil

Dr. Ackerman served in a variety of management positions at Cygnus, Inc from 1994-2005.
He initially led the development efforts for a number of transdermal products, two of which were approved.
He then led the R&D, clinical, regulatory and compliance functions for the Glucowatch Biographer, the first commercially available non-invasive glucose monitor.
From 1990-1994 he was Vice President, Research and Development at Glycomed, leading its discovery efforts in cardiovascular and inflammatory diseases.
From 1982-1990, he was Research Director, Cancer and Inflammatory Diseases with DuPont Pharmaceuticals.
Prior to that time, he had research and management positions at Syntex Corporation and Pfizer, Inc. He is currently an advisor to MMV Financial.
Dr. Ackerman received his Ph.D.
degree from the University of Maryland, and completed a post-doctoral fellowship in immunology at Stanford University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
05/05/2023 62 378 ( 0,01% ) 4 M $ 31/05/2024

Anciens postes connus de Neil R. Ackerman

SociétésPosteFin
Directeur Technique/Scientifique/R&D 01/04/2005
Corporate Officer/Principal -
Voir l'expérience en détail de Neil R. Ackerman

Formation de Neil R. Ackerman

University of Maryland Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Neil R. Ackerman

Relations

14

Relations au 1er degré

3

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées2

Health Technology

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Neil R. Ackerman